These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1201206)

  • 1. A comparison between radioimmunoassay and other immunological techniques for the measurement of fibrinogen/fibrin degradation products in serum.
    Ratky SM; Martin MJ; Gordon YB; Baker LR; Chard T; Leslie J
    Br J Haematol; 1975 Jun; 30(2):145-9. PubMed ID: 1201206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
    Wilson JE; Thornton RD
    Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
    Marder VJ; Cruz GO; Schumer BR
    Thromb Haemost; 1977 Apr; 37(2):183-91. PubMed ID: 577622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.
    Garvey MB; Black JM
    J Clin Pathol; 1972 Aug; 25(8):680-2. PubMed ID: 5076802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum.
    Chi DS; Chen JP
    Thromb Haemost; 1976 Apr; 35(2):423-36. PubMed ID: 823661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of two new assays for determination of serum fibrinogen/fibrin degradation products.
    Sumner K; Feller E; Galanakis DK; Mosesson MW
    Ann Clin Lab Sci; 1979; 9(5):362-7. PubMed ID: 533231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of radioimmunoassays for fibrinogen degradation products: fragments D and E.
    Gordon YB; Martin MJ; Landon J; Chard T
    Br J Haematol; 1975 Jan; 29(1):109-19. PubMed ID: 1201195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of fibrinogen antigens with two latex techniques applied to urine concentrates.
    Donati MB; Semeraro N; Vermylen J
    J Clin Pathol; 1973 Oct; 26(10):760-3. PubMed ID: 4201501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False-negative test for fibrinogen--fibrin degradation products.
    Kickler T; Bell WR
    Am J Clin Pathol; 1977 Jul; 68(1):78-80. PubMed ID: 868807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of FDP in human plasma by a novel latex immunoassay.
    Sakai Y; Maeda M; Takei F; Matsumoto T; Nishijima Y; Nakamura K
    Thromb Res; 1988 May; 50(4):469-79. PubMed ID: 3413715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional detection method of fibrinogen and fibrin degradation products using latex piezoelectric immunoassay.
    Aizawa H; Kurosawa S; Tozuka M; Park JW; Kobayashi K; Tanaka H
    Biosens Bioelectron; 2003 May; 18(5-6):765-71. PubMed ID: 12706590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen-fibrin degradation products: hemagglutination inhibition immunoassay in plasma.
    Chi DS; Chen JP
    Tex Rep Biol Med; 1975; 33(4):493-508. PubMed ID: 133472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
    Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
    Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
    Greenberg CS; Devine DV; McCrae KM
    Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Am J Clin Pathol; 1986 Mar; 85(3):360-4. PubMed ID: 2875646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tanned red cell haemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products.
    Kings GL; Stoodley KD
    Med Lab Sci; 1980 Oct; 37(4):317-22. PubMed ID: 7207041
    [No Abstract]   [Full Text] [Related]  

  • 19. [FDP (fibrinogen degradation products) determination by TRCHII (tanned red cell haemogglutination inhibition immunoassay) method].
    Abe K; Endo E; Kato M
    Rinsho Byori; 1971 Aug; 19():Suppl:256. PubMed ID: 5290295
    [No Abstract]   [Full Text] [Related]  

  • 20. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.